Qiagen N.V. (QGEN)
NYSE: QGEN · Real-Time Price · USD
36.87
+0.74 (2.05%)
May 28, 2026, 2:06 PM EDT - Market open
Qiagen Employees
Qiagen had 5,700 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
5,700
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$368,222
Profits / Employee
$70,555
Market Cap
7.62B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 5,700 | 0 | - |
| Dec 31, 2024 | 5,700 | -267 | -4.47% |
| Dec 31, 2023 | 5,967 | -211 | -3.42% |
| Dec 31, 2022 | 6,178 | 150 | 2.49% |
| Dec 31, 2021 | 6,028 | 418 | 7.45% |
| Dec 31, 2020 | 5,610 | 514 | 10.09% |
| Dec 31, 2019 | 5,096 | 144 | 2.91% |
| Dec 31, 2018 | 4,952 | 264 | 5.63% |
| Dec 31, 2017 | 4,688 | 4 | 0.09% |
| Dec 31, 2016 | 4,684 | 125 | 2.74% |
| Dec 31, 2015 | 4,559 | 220 | 5.07% |
| Dec 31, 2014 | 4,339 | 324 | 8.07% |
| Dec 31, 2013 | 4,015 | 16 | 0.40% |
| Dec 31, 2012 | 3,999 | 61 | 1.55% |
| Dec 31, 2011 | 3,938 | 351 | 9.79% |
| Dec 31, 2010 | 3,587 | 92 | 2.63% |
| Dec 31, 2009 | 3,495 | 454 | 14.93% |
| Dec 31, 2008 | 3,041 | 379 | 14.24% |
| Dec 31, 2007 | 2,662 | 708 | 36.23% |
| Dec 31, 2006 | 1,954 | 365 | 22.97% |
| Dec 31, 2005 | 1,589 | 267 | 20.20% |
| Dec 31, 2004 | 1,322 | -231 | -14.87% |
| Dec 31, 2003 | 1,553 | -98 | -5.94% |
| Dec 31, 2002 | 1,651 | 94 | 6.04% |
| Dec 31, 2001 | 1,557 | 242 | 18.40% |
| Dec 31, 2000 | 1,315 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ICON Public Limited Company | 41,900 |
| Charles River Laboratories International | 19,700 |
| Revvity | 11,000 |
| RadNet | 9,276 |
| Medpace Holdings | 6,200 |
| Sotera Health Company | 3,000 |
| Guardant Health | 2,506 |
| Twist Bioscience | 979 |
QGEN News
- 7 days ago - QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows - Business Wire
- 8 days ago - Qiagen Digital Insights to integrate Nvidia accelerated computing - TheFly
- 8 days ago - QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA - Business Wire
- 10 days ago - Qiagen price target lowered to $36 from $50 at Stifel - TheFly
- 15 days ago - Qiagen Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 15 days ago - Qiagen Slides: FY 2026 - Filings
- 16 days ago - QIAGEN to Appoint Dr. Metin Colpan as Honorary Chairman of the Supervisory Board, Continue Governance Renewal and Propose Increased Returns at 2026 Annual General Meeting - Business Wire
- 20 days ago - Qiagen price target lowered to $40 from $46 at TD Cowen - TheFly